Lord, Abbett & Co. LLC Epizyme, Inc. Transaction History

Lord, Abbett & Co. LLC

  • $30.6 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018
SELL
$12.85 - $18.45 $6.15 Million - $8.83 Million
-478,793 Closed
0 $0
Q1 2018

May 15, 2018
SELL
$12.5 - $19.75 $3,250 - $5,135
-260 Reduced 0.05%
478,793 $8.5 Million
Q4 2017

Feb 14, 2018
SELL
$11.55 - $20.1 $1.74 Million - $3.03 Million
-150,613 Reduced 23.92%
479,053 $6.01 Million
Q3 2017

Nov 14, 2017
SELL
$12.7 - $19.25 $183,070 - $277,488
-14,415 Reduced 2.24%
629,666 $12 Million
Q2 2017

Aug 14, 2017
BUY
N/A
644,081
644,081 $9.73 Million

About Epizyme, Inc.

EPZM Quotes by TradingView
  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email